Yuxiao Wang joined Myeloid Therapeutics in March 2019 as one of the co-founder. He received Ph.D. in Molecular Biophysics from the University of Texas Southwestern Medical Center and performed postdoctoral research at Prof. Ron Vale’s laboratory in University of California, San Francisco. Yuxiao published several papers in transmembrane receptor signaling, T cell signal transduction and membrane trafficking. Yuxiao Wang received the Jane Coffin Childs Fellowship Award (2014) and the UCSF Independent Research Award (2017).